2. Academic Validation
  3. PAR4 (Protease-Activated Receptor 4): PARticularly Important 4 Antiplatelet Therapy

PAR4 (Protease-Activated Receptor 4): PARticularly Important 4 Antiplatelet Therapy

  • Arterioscler Thromb Vasc Biol. 2018 Feb;38(2):287-289. doi: 10.1161/ATVBAHA.117.310550.
Xu Han 1,  Marvin T Nieman 2
Affiliations

Affiliations

  • 1 From the Department of Pharmacology, Case Western Reserve University, Cleveland, OH.
  • 2 From the Department of Pharmacology, Case Western Reserve University, Cleveland, OH. [email protected].
PMID: 29367229 DOI: 10.1161/ATVBAHA.117.310550
Figures